Precision Medicine News and Research

RSS

Novel method for evaluating genomic sequencing results in newborn screening

Newborn screening is required in the U.S. and differs slightly depending on which state you live in. For the most part, it's done before a newborn baby leaves the hospital and includes a blood test that screens for 30-50 serious health problems that usually arise in infancy or childhood, and could hinder normal development.

26 May 2019

New statement emphasizes need for special multidisciplinary clinical programs

With a better understanding of how various heart conditions are inherited, and the availability of faster and less expensive genetic testing, there is need for more specialized multidisciplinary clinical programs that combine focused expertise in heart disease and genetics, according to a new statement from the American Heart Association, the world's leading voluntary organization focused on heart and brain health.

25 May 2019

Are fruit fly 'avatars' the next step in personalized medicine?

Researchers have created fruit fly “avatars” that have helped to guide treatment for a man who had terminal colon cancer.

24 May 2019

ESSA’s position statement on exercise guidelines for people with cancer

A decade-old treatment recommendation for people with cancer to take a "slowly slowly" approach to exercise has been replaced with new guidelines recommending a personalized exercise program including high-intensity workouts to achieve the best treatment outcome.

23 May 2019

Study revolutionizes treatment principles for functional mitral regurgitation

For years now, cardiology experts have been arguing about how to determine the degree of severity in patients with functional mitral regurgitation and, hence, to assess when it is necessary to operate on the valve.

23 May 2019

New cell co-culture platform holds promise for future of personalized medicine

Why doesn't the same treatment work in the same way for every patient?

22 May 2019

Owlstone Medical announces strategic collaboration with Actelion to improve lives of people with pulmonary hypertension

Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine today announces a strategic collaboration with Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and a global leader in pulmonary arterial hypertension, to discover and validate a breath-based test to help facilitate the early diagnosis of pulmonary hypertension and its subtypes.

From Owlstone Medical Ltd 21 May 2019

Using artificial intelligence to identify socially isolated prostate cancer patients

We fare better during health challenges when we have a little help from our friends, family and community. And perhaps an assist from artificial intelligence.

17 May 2019

Over-fed bacteria in the gut promote disease development

Since the end of the Second World War, along with the growing prosperity and the associated changes in lifestyle, numerous new and civilisation-related disease patterns have developed in today's industrialised nations.

16 May 2019

Machine learning tool immensely scales up Alzheimer's research

Researchers at UC Davis and UC San Francisco have found a way to teach a computer to precisely detect one of the hallmarks of Alzheimer's disease in human brain tissue, delivering a proof of concept for a machine-learning approach to distinguishing critical markers of the disease.

15 May 2019

Rare gene mutation may prevent heart disease, study reveals

Targeting apolipoprotein B gene has not been tested in clinical trials for cardiovascular outcomes because of risk of fatty liver disease, but naturally-occurring mutation suggests it may be effective.

13 May 2019

Quanterix corporation releases operating results for first quarter 2019

Quanterix announced financial results for the three months ended March 31, 2019.

From Quanterix 10 May 2019

HSS researchers provide better understanding of the cellular mechanisms driving rheumatoid arthritis

Newly identified subsets of cell types present in joint tissue in people with rheumatoid arthritis and how they interact may explain why only some people respond to existing medications, according to two studies by co-senior author Laura Donlin, PhD, Co-Director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery and collaborating colleagues.

10 May 2019

Promising radioisotope couple for cancer diagnosis and therapy

Researchers at Kanazawa University report in ACS Omega a promising combination of radioisotope-carrying molecules for use in radiotheranostics — a diagnosis-and-treatment approach based on the combination of medical imaging and internal radiation therapy with radioactive elements.

9 May 2019

Study could lead to improved diagnosis and treatment of ovarian cancer

Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta.

8 May 2019

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.

6 May 2019

Biomarker may help predict first treatment option for metastatic colorectal cancer patients

Foundational research by a City of Hope physician-scientist and his colleagues could one day help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as their first treatment option.

2 May 2019

Researchers use 3D printer to make paper organs

Long before scientists test new medicines in animals or people, they study the effects of the substances on cells growing in Petri dishes.

1 May 2019

Multigene test helps doctors to make effective treatment decisions for breast cancer patients

A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.

30 Apr 2019

Precision medicine for pediatric tumors can now be a reality, shows study

Five years after it was created to serve children and adolescents in Quebec, the TRICEPS team at CHU Sainte-Justice has demonstrated the feasibility of setting up a research program in pediatric oncology precision medicine, as described in a recent article published in the JAMA Network Open journal.

30 Apr 2019